<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000597169"><TermName>radioimmunotherapeutics</TermName><TermPronunciation>(RAY-dee-oh-IH-myoo-noh-THAYR-uh-PYOO-tix)</TermPronunciation><TermDefinition><DefinitionText>The use of radiolabeled monoclonal antibodies to treat diseases, including cancer. The radiolabeled monoclonal antibody locates and binds to substances in the body, including cancer cells. Radiation given off by the radioisotope may help kill the cancer cells.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720972" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;radioimmunotherapeutics&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720973" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;radioinmunoterapéutico&quot;" language="es" id="_4"/><SpanishTermName>radioinmunoterapéutico</SpanishTermName><SpanishTermDefinition><DefinitionText>Uso de anticuerpos monoclonales radiomarcados para ayudar a diagnosticar enfermedades, incluso el cáncer. Los anticuerpos monoclonales radiomarcados localizan sustancias en el cuerpo, como las células cancerosas, y se unen a ellas. La radiación emitida por el radioisótopo puede ayudar a destruir las células cancerosas.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-05-30</DateFirstPublished></GlossaryTerm>
